Caption Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Caption Management's GILD Position: Q4 2025 in Review
Caption Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 49,900 shares — an estimated $6.06M sold.
Caption Management first reported a position in GILD in Q3 2019 and held it in 9 quarters. The position peaked at $16.5M in Q2 2025. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Caption Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Caption Management sold 49,900 Gilead Sciences shares in Q4 2025, an estimated $6.06M.
- Caption Management first reported a position in Gilead Sciences in Q3 2019 and held it in 9 quarters.
- Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
- 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.